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Background
Occupations as an Outcome Measure in a Clinical Trial:  
Fragile X Syndrome and Sertraline (Preliminary Results) 
Michelle Beckwith, OTS | Brina Nguyen, CAPS, OTS | Jennifer Sik, OTS | Kenneth Yu, OTS | Laura Greiss Hess, PhD, OTR/L (Faculty Advisor) 
Dominican University of California | Department of Occupational Therapy
Fragile X Syndrome (FXS) is the most 
common form of inherited intellectual and 
developmental disability.
 Offers a genetic model to 
understanding autism spectrum 
disorder
 Manifests with behavioral 
problems, anxiety, and sensory 
processing difficulties
A battery of standardized, norm-
referenced assessments and parent 
checklists are frequently used as 
outcome measures in clinical trials.
✦ The addition of interview 
methods will provide family voice 
and personal stories thus affording: 
• An occupation-centered lens 
to empirically examine living with 
FXS and the impact on family 
life
• A measurement for 
contextually-based changes 





Can qualitative interview methods serve as 
an outcome measure capturing changes in 
occupational performance between 
treatment and placebo groups?
(Hagerman, Hoem, & Hagerman, 2010; Hagerman, Lauterborn, Au, & Berry-Kravis, 
2012; Hess et al., 2016; Hessl et al., 2016; NFXF, 2016;  Wang, Berry-Kravis, & 
Hagerman, 2010).
 Sample Interview Question and 
Preliminary trends indicated improvements in the sertraline treatment group compared to the 
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Percentage of Reported Improvements
Design:  Qualitative (interview methods)
Population:  Families with children 
diagnosed with full mutation FXS 
enrolled in UC Davis MIND 
Institute sertraline (Zoloft®) 
clinical trial




(Hess et al., 2016)UC Davis MIND Institute RCT
Data Collection
✦ Obtained IRB approval & consent
✦ Interviews transcribed using ExpressScribe®
Data Analysis
✦ Constant comparison method (CCM)
•Operationalization of codes & themes
✦ All coding blind to group assignment
•Each researcher assigned 3 transcripts
✦ Individual coding of data
✦ CCM & re-operationalization of codes & themes
✦ Independently reviewed all coded excerpts
✦ Consensus coding of 100% codes
“Have you noticed any changes related to 
anxiety/communication/behavior/sensory? 
How has that impacted you as a family?”
Results
“I think he maybe is on the real meds because 
he is sort of dealing with his anxiety better. I 
am finding that it’s not such of a struggle. His 
episodes aren’t as big. They are still there. He’s 
getting better at transitioning into getting into 
the next thing.”
Anxiety
“He has improved tremendously. He is using 
more signs, he is very expressive, he uses his 
facial expressions to show us how he is 
feeling.”
Communication
“He has calmed down.  He’s more interactive 
with play.  Doing his own play things, playing 





Baseline Interview and Assessment
6 month controlled trial
Post-Interview and Assessment
(Corbin & Strauss, 1994)
 Anxiety
 Expressive & receptive communication
 Maladaptive behaviors
 Sensory (Less)
“I think the fact that we expose him to so 
many things, like grocery shopping. So he is not 
afraid of being in a big noisy space with lights.”
Sensory Strategies/Community & Social 
✦  This preliminary data did show differences between 
groups in several areas
✦ Occupational therapy intervention and clinical research 
should include parent perspectives, not just 
standardized assessments
✦ Families within the FXS community felt a sense of 
altruism from participating in the study
✦ Future directions to include a larger sample for analysis
The sertraline group did not show greater improvements than the placebo group in the 
following areas:
 Community/social  Sensory (More)
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This Study
*Sensory Less: Self-stim, Seeking, Avoiding, Defensiveness *Sensory More: Tolerant, Exploratory     *Behavior Less: Fuss, Crying, Upset, Tantrums, Frustration    *Behavior More: Attention, Independence, Purpose
